Oramed Pharmaceuticals, Inc. (ORMP)
5.355
+0.14
(+2.78%)
USD |
NASDAQ |
Aug 26, 16:00
5.355
0.00 (0.00%)
After-Hours: 16:19
Oramed Pharmaceuticals Total Assets (Quarterly) : 369.64M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 369.64M |
| March 31, 2026 | 268.85M |
| December 31, 2025 | 230.86M |
| September 30, 2025 | 220.49M |
| June 30, 2025 | 161.68M |
| March 31, 2025 | 147.54M |
| December 31, 2024 | 155.28M |
| September 30, 2024 | 165.08M |
| June 30, 2024 | 184.22M |
| March 31, 2024 | 203.65M |
| December 31, 2023 | 220.55M |
| September 30, 2023 | 230.89M |
| June 30, 2023 | 156.31M |
| March 31, 2023 | 159.78M |
| December 31, 2022 | 161.64M |
| September 30, 2022 | 164.44M |
| June 30, 2022 | 162.29M |
| March 31, 2022 | 172.22M |
| August 31, 2021 | 128.00M |
| May 31, 2021 | 80.49M |
| February 28, 2021 | 61.66M |
| November 30, 2020 | 40.97M |
| August 31, 2020 | 44.63M |
| May 31, 2020 | 46.16M |
| February 29, 2020 | 29.88M |
| Date | Value |
|---|---|
| November 30, 2019 | 31.14M |
| August 31, 2019 | 34.66M |
| May 31, 2019 | 37.43M |
| February 28, 2019 | 41.81M |
| November 30, 2018 | 43.59M |
| August 31, 2018 | 47.40M |
| May 31, 2018 | 34.66M |
| February 28, 2018 | 38.25M |
| November 30, 2017 | 41.54M |
| August 31, 2017 | 38.71M |
| May 31, 2017 | 39.79M |
| February 28, 2017 | 41.84M |
| November 30, 2016 | 44.93M |
| August 31, 2016 | 42.83M |
| May 31, 2016 | 36.30M |
| February 29, 2016 | 38.37M |
| November 30, 2015 | 23.88M |
| August 31, 2015 | 26.35M |
| May 31, 2015 | 22.13M |
| February 28, 2015 | 22.98M |
| November 30, 2014 | 24.56M |
| August 31, 2014 | 21.80M |
| May 31, 2014 | 22.50M |
| February 28, 2014 | 23.71M |
| November 30, 2013 | 8.006M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 142.28B |
| Pfizer Inc. | 201.13B |
| Yarrow Bioscience, Inc. | 23.60M |
| Liquidia Corp. | 521.92M |
| NRX Pharmaceuticals, Inc. | 34.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 52.17M |
| Shareholders Equity (Quarterly) | 317.47M |
| Debt to Equity Ratio | 0.0023 |
| Current Ratio | 4.977 |
| Net Debt Paydown Yield | -0.04% |